Personalised Medicine in Cervical Cancer: Evaluating Therapy Resistance Through Multi‐Model Approaches

Mikaël Meyer(Stellenbosch University), Anna‐Mart Engelbrecht(Stellenbosch University)
Cancer Medicine
June 26, 2025
10.1002/cam4.70995
Cited by 1

Related Papers

Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance
|Journal of Translational Medicine|2015|39
Decreased Efficacy of Doxorubicin Corresponds With Modifications in Lipid Metabolism Markers and Fatty Acid Profiles in Breast Tumors From Obese vs. Lean Mice
|Frontiers in Oncology|2020|39
The effect of dietary red palm oil on the functional recovery of the ischaemic/reperfused isolated rat heart: the involvement of the PI3-Kinase signaling pathway
|Lipids in Health and Disease|2009|17